Latest posts
-
SiBionics PharmaSens: The Race to a Single-Patch Artificial Pancreas
SiBionics and PharmaSens have shown that a single-patch artificial pancreas — CGM, insulin delivery and algorithm in one wearable — is feasible. It’s a real milestone, but the device is investigational and the accuracy isn’t there yet.
-
Music Therapy Research: What THEi’s Shenzhen Launch Doesn’t Prove
THEi launched a music therapy research centre in Shenzhen with concerts, MoUs and AI promises. The demand is real — the licences, job codes and clinical evidence are not, yet.
-
The Misfit Collaborative: A Neurodiversity Platform Entering a Crowded Field
The Misfit Collaborative promises to connect families, schools, and workplaces with vetted neurodiversity practitioners. The release names no vetting criteria, no pricing, and no practitioner count — and at least two direct competitors launched in the same month.
-
Abacus AI3 Initiative: A Governance-First AI Pitch From a Post-Merger MSP
Abacus AI3 promises governance-first AI adoption for healthcare and financial services firms. The partnerships are unnamed in nature, the dozen Claude deployments are modest in scale, and the release omits the merger that created the firm.
-
Needle-Free Skin Tightening: OrangeTwist Launches Density Nationwide
OrangeTwist has launched Density nationwide, an FDA-cleared needle-free dual radiofrequency treatment designed to improve skin firmness, elasticity and texture without surgery or downtime.